Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- Ingestive behavior, feeding & metabolic control
- What are “Ingestive Peptides”?
- The blood-brain barrier (BBB)
- Interactions of a peptide with the BBB
- Time regression analysis of BBB permeability
- Internal control / degradation assays
- Leptin enters the brain by a saturable system
- Leptin and obesity
- Regulation of leptin transport (case study)
- “Leptin Resistance” at multi-levels
- The physiological regulation of leptin transport
- Regulation of leptin transport in fasting
- Anorectic and orexigenic peptides
- Understand brain mechanisms through CSF
- Insulin transport across the BBB
- Leptin & urocortin interactions are not reciprocal
- BBB interactions of ingestive peptides
- BBB permeation of ingestive peptide
- BBB around the hypothalamus
- Diffusion barrier between median eminence
- A palisading astrocyte barrier
- The Circumventricular Organs (CVOs)
- The BBB is an immense exchange interface
Topics Covered
- Blood-brain barrier (BBB) permeation of ingestive peptides
- Leptin as a major example
- Receptor-mediated transport
- Modulation by feeding status
- Activation of other systems such as that of urocortin
- Multi-modality, including specific transport and simple diffusion
- Direct actions and generation of secondary mediators at the level of BBB endothelia
- The BBB, BCSFB, and circumventricular organs (CVOs)
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Pan, W. (2019, February 27). Brain-gut interactions in obesity 1 [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 7, 2024, from https://doi.org/10.69645/MKPQ9659.Export Citation (RIS)
Publication History
Financial Disclosures
- Professor Weihong Pan has no commercial/financial relationships to disclose
Brain-gut interactions in obesity 1
Published on February 27, 2019
33 min
A selection of talks on Neuroscience
Transcript
Please wait while the transcript is being prepared...
0:00
Hello everyone. This is Dr. Weihong Pan from
BioPotentials Consulting in Sedona, Arizona in the USA,
the co-editor of this Henry Stewart series on the blood-brain barrier.
In this talk, I will provide an update of
the interactions of ingestive peptides with the blood-brain barrier;
Dr. Bill Banks has summarized the essential background in
his 2008 slide set for this BBB series of the Henry Stewart talks.
This past decade has seen many exciting paradigm shifts.
I will mainly discuss the progress on this subject post 2008.
0:39
Here is the outline of this talk.
First, I will continue from what Banks started in
his 2008 talk on the subject of ingestive peptides crossing the blood-brain barrier.
There are several points that I want to make.
The prototypical leptin reaches the brain mainly by saturable
receptor-mediated transport systems at the blood-brain barrier and blood CSF barrier.
Leptin also modulates the permeation of other ingestive peptides, particularly urocortin.
However, specific and separable transport systems are
not the only way by which ingestive peptides reach the CNS.
Some peptides may cross the BBB by simple diffusion, resulting from
relatively high lipophilicity and/or generate
secondary mediators at the level of the BBB endothelial,
though they, themselves lack meaningful penetration across the BBB.
Besides blood-brain and blood CSF barriers,
I will discuss the contribution of circumventricular organs, or CVOs in short,
and a neuroendocrine modulation of feeding.
Along with the retrograde axonal transport and the brain reward system,
brain barrier systems contribute to the regulation of feeding behavior.
Second, I will discuss glial biology regarding feeding and obesity regulation.
This is mainly based on studies originating from
our own laboratory and popularized in the past decade.
Third, I will briefly discuss the latest hot topic of the gut as a large immune organ,
and how the BBB is involved in gut-brain interactions in this aspect.
There are global changes in the BBB that occur during metabolic syndromes.
This is mainly shown by proteomic studies with follow up at mRNA,
protein, and functional levels.
I hope that these findings will provide a broad perspective of BBB mediated regulation in
obesity and neuro-inflammation that may eventually lead to neurodegenerative diseases.